UMN Pharma Inc. engages in the development and manufacture of biopharmaceuticals in Japan and internationally. The company’s products include UMN-0502, a seasonal influenza vaccine; UMN-0501 and UMN-0901, which are pandemic influenza vaccines; and UMN-2003, a norovirus VLP + rotavirus VP6 non-live injectable trivalent vaccine for the prevention of causative agents of acute gastroenteritis. The company was incorporated in 2004 and is headquartered in Yokohama, Japan.
umn pharma inc (4585:Tokyo)
NOF Shin-yokohama Building
Phone: 81 45 624 8341
Fax: 81 45 624 8342www.umnpharma.com/en
|No competitor information is available for 4585.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact UMN PHARMA INC, please visit www.umnpharma.com/en. Company data is provided by Capital IQ. Please use this form to report any data issues.